secwatch / observer

Nordicus Partners Corp — fact timeline

Source-grounded facts extracted from Nordicus Partners Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

NORD Nordicus Partners Corp JSON
Material Agreements

Nordicus Partners Corp entered into a equity purchase with ten private investors valued at $2.75 per share.

“In December 2025, we issued to ten private investors a total of 131,000 restricted shares of our common stock, par value $0.01 per share. The price per share was $2.75.”

Peter Severin was appointed as Chairman of the Board of Directors at Nordicus Partners Corp.

“and the remaining Board members appointed Peter Severin as his replacement and as Chairman of the Board of Directors.”

Christian Hill-Madsen resigned as Director at Nordicus Partners Corp.

“Effective June 3, 2024, Christian Hill-Madsen resigned from the Board of Directors of Nordicus Partners Corporation (the “Company”), and the remaining Board members appointed Peter Severin as his replacement and as Chairman of the Board of Directors.”
M&A Transactions

Nordicus Partners Corp completed an acquisition involving certain shareholders of Orocidin A/S (closed 2024-05-13).

“the Company acquired the Orocidin Shares pursuant to the Agreement.”
Material Agreements

Nordicus Partners Corp entered into Stock Purchase and Sale Agreement with certain shareholders of Orocidin A/S (effective 2024-05-13).

“On May 13, 2024, Nordicus Partners Corporation (the “Company”) and certain shareholders (the “Sellers”) of Orocidin A/S, a Danish stock corporation (“Orocidin”) entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which the Sellers sold to the Company 525,597 shares of the capital stock of Orocidin (the “Orocidin Shares”), representing 95.0% of Orocidin’s outstanding shares of capital stock.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.